The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In vitro diagnostic (IVD) investigations are indispensable for routine patient management. Appropriate testing allows early-stage interventions, reducing late-stage healthcare expenditure (HCE). AIM: To investigate HCE on IVDs in two developed markets and to assess the perceived value of IVDs on clinical decision-making. Physician-perceived HCE on IVD was evaluated, as well as desired features of new diagnostic markers. METHODS: Past and current HCE on IVD was calculated for the US and Germany. A total of 79 US/German oncologists and cardiologists were interviewed to assess the number of cases where: physicians ask for IVDs; IVDs are used for initial diagnosis, treatment monitoring, or post-treatment; and decision-making is based on an IVD test result. A sample of 201 US and German oncologists and cardiologists was questioned regarding the proportion of HCE they believed to be attributable to IVD testing. After disclosing the actual IVD HCE, the physician's perception of the appropriateness of the amount was captured. Finally, the association between physician-rated impact of IVD on decision-making and perceived contribution of IVD expenditure on overall HCE was assessed. RESULTS: IVD costs account for 2.3% and 1.4% of total HCE in the US and Germany. Most physicians (81%) believed that the actual HCE on IVDs was >5%; 19% rated the spending correctly (0-4%, p<0.001). When informed of the actual amount, 64% of physicians rated this as appropriate (p<0.0001); 66% of decision-making was based on IVD. Significantly, more physicians asked for either additional clinical or combined clinical/health economic data than for the product (test/platform) alone (p<0.0001). CONCLUSIONS: Our results indicate a poor awareness of actual HCE on IVD, but a high attributable value of diagnostic procedures for patient management. New markers should deliver actionable and medically relevant information, to guide decision-making and foster improved patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A significant proportion, 66 %, of clinical decisionmaking is based on in vitro diagnostics (IVD) [15].”
From Machine learning-based clinical decision support using laboratory data (2024) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Porter, M. E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1011024 · Cited by 5,084
Schnipper, L. E., Davidson, N. E., Wollins, D. S., Tyne, C., Blayney, D. W., Blum, D., Dicker, A. P., Ganz, P. A., Hoverman, J. R., Langdon, R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6706 · Cited by 912
The cervical cancer epidemic that screening has prevented in the UK
Peto, J., Gilham, C., Fletcher, O., & Matthews, F. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16674-9 · Cited by 808
Errors in clinical laboratories or errors in laboratory medicine?
Plebani, M. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.123 · Cited by 734
HER2 testing in gastric cancer: a practical approach
Rüschoff, J., Hanna, W., Bilous, M., Hofmann, M., Osamura, R. Y., Penault-Llorca, F., van de Vijver, M., & Viale, G. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.198 · Cited by 595
The Landscape of Inappropriate Laboratory Testing: A 15-Year Meta-Analysis
Zhi, M., Ding, E. L., Theisen-Toupal, J., Whelan, J., & Arnaout, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078962 · Cited by 535 · cited 1×
“Interestingly is also the fact that there were four times as many studies found on over- compared to underutilization during the assessed 15-year period and, despite in-depth literature research, only 42 studies finally matched the criteria for review, indicating a poor level of evidence on inappropriate use of IVD te…”
ResultThe detection and prevention of errors in laboratory medicine
Plebani, M. (2010) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009222 · Cited by 479
Jeremias, A., & Gibson, C. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-9-200505030-00015 · Cited by 466
Redefining Competition in Health Care
Hester, C. (2004) · Harvard business review · Cited by 384
Research works printed but not linked: 2
- Raman G, Avendano E, Chen M. Update on Emerging Genetic Tests Currently Available for Clinical Use in Common Cancers, in Technology Assessment Report Rockville, MD: Agency for Healthcare Research and Quality; 2013. 25905153
- Quest Diagnostics 31st Annual J. P. Morgan Healthcare Conference January 9, 2013. Available: http://ir.questdiagnostics.com/phoenix.zhtml?c=82068&p=irol-presentations.
Cited by
Items 101–200 of 233
Mrosewski, I., Dähn, T., Hehde, J., Kalinowski, E., Lindner, I., Meyer, T. M., Olschinsky-Szermer, M., Pahl, J., Puls, M., Sachse, K., et al. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-1265 · Cited by 6
Establishing Pediatric Reference Ranges for Rotational Thromboelastometry
Meyer, E. K. G., Uffman, J. C., Townsend, S. M., Rice‐Weimer, J., Tobias, J. D., & Nicol, K. K. (2023) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqad015 · Cited by 6
Lamovšek, N., & Klun, M. (2020) · Central European Public Administration Review · doi:10.17573/cepar.2020.1.07 · Cited by 6
Wempe, M. M., Stewart, M. D., Glass, D., Lasiter, L., Vega, D. M., Ramamurthy, N., Allen, J. D., & Sigal, E. V. (2020) · PubMed · Cited by 6
Пискунов, Д. П., Danilova, L. A., Pushkin, A. S., & Рукавишникова, С. А. (2020) · Russian Clinical Laboratory Diagnostics · doi:10.18821/0869-2084-2020-65-12-778-784 · Cited by 8
PDTA e Medicina di Laboratorio
Cappelletti, P. (2017) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.1007/s13631-017-0154-x · Cited by 6
“Infatti, uno studio tedesco [38], citato anche da Rohr et al [37], ha dimostrato che il 32% (187 su 584) delle diagnosi cliniche esaminate viene confermato dal solo uso di esami di laboratorio.”
BackgroundThe Model List of Essential In Vitro Diagnostics: nuisance or opportunity?
Lippi, G., Plebani, M., & Favaloro, E. J. (2018) · Diagnosis · doi:10.1515/dx-2018-0035 · Cited by 6
Numerical modeling and experimental validation of fluid flow in micro- and meso-fluidic siphons
Akhras, N., Singh, G., Gill, K. K., Bola, S., Al-Hakeem, K., & Reis, N. M. (2024) · Frontiers in Chemical Engineering · doi:10.3389/fceng.2024.1443949 · Cited by 5
“Diagnostic tests are now routinely informing 60% – 70% of clinical decisions (Rohr et al., 2016; Sikaris, 2017), and many patient pathways already include a form of patient strati fi cation or diagnosis based on the quantitation of at least one biomarker.”
Çubukçu, H. C., Zengi, O., Hakan, H., Cihan, M., Uçar, K. T., Thelen, M., & Panteghini, M. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120355 · Cited by 5
Casas, M. L. M. D. L., Esteban, Á., González‐Muñoz, M., Labrador‐Horrillo, M., Pascal, M., & Teniente‐Serra, A. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2020-0022 · Cited by 7
“Es importante que los especialistas que trabajan en el área de la inmunoalergología conozcan en profundidad las características técnicas de cada una de las metodologías disponibles, así como las diferencias entre ellas, lo que permitirá entender las implicaciones de un cambio de técnica y los costes derivados de ello,…”
BackgroundGyörfi, I., Pál, K., Mănescu, I. B., Oprea, O. R., & Dobreanu, M. (2021) · Revista română de medicină de laborator · doi:10.2478/rrlm-2021-0027 · Cited by 6
Somerville, M., Cassidy, C. E., Curran, J., Rothfus, M. A., Sinclair, D. E., & Rose, A. E. (2022) · Health Research Policy and Systems · doi:10.1186/s12961-022-00898-z · Cited by 7
Overview of the Implementation of Quality Management System in Nigerian Medical Laboratories
Nwaokorie, F. O., & Ojo, E. O. (2018) · University of Lagos Journal of Basic Medical Sciences · doi:10.52968/23685335 · Cited by 11
Unmet Diagnostics Needs for the Developing World
Land, K. J., Smith, S., & Peeling, R. W. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-96870-4_1 · Cited by 5
Omidifar, N., Bafti, A. H., Shokripour, M., Amini, M., Rojas, I. E. E., & Moghimizadeh, M. (2022) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_470_21 · Cited by 6
“Furthermore, 66% of clinical decisions are made based on in vitro diagnosis.[7] Pathologists are key members of modern medicine teams; their involvement is crucial in all stages of the patient’s management process, from diagnosis to discharge.”
BackgroundA Novel High-Throughput and Sensitive Electrochemiluminescence Immunoassay System
Liu, X., Zhao, S., Xu, Y., Zhang, B., Huang, J., Liu, F., Yang, N., Lu, W., Shi, D., Xie, D., et al. (2024) · Bioengineering · doi:10.3390/bioengineering11090885 · Cited by 4
“There are numerous subdivisions of IVDs, including biochemical diagnostics, immunological diagnostics, molecular diagnostics, microbiological diagnostics, etc., among which immunological diagnostics account for the largest proportion [1].”
BackgroundAssessment of regulation on vitamin D test requesting in terms of the rational laboratory use
Yılmaz, G., Aydoğan, N., Sezer, S., Tutar, S., Uzdoğan, A., Erel, Ö., & Yılmaz, F. M. (2020) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2020-0175 · Cited by 6
Erros relacionados ao laboratório
Shcolnik, W. (2019) · Editora FIOCRUZ eBooks · doi:10.7476/9788575416419.0014 · Cited by 4
Frequency of Repeating Antinuclear Antibody Testing: When Less Is More
Alyami, M. B., Hakeem, M. N., Fadil, A. I., Jee, B. A., Elabbasy, H. M., & Ankawi, G. (2024) · Cureus · doi:10.7759/cureus.52347 · Cited by 5
“Although laboratory investigations only represent 2.3% and 1.4% of total healthcare expenditure (HCE) in the United States and Germany, respectively [4], the downstream payment of laboratory investigations is undoubtedly expected to be larger, especially if inappropriately ordered, as…”
BackgroundInfluentialExternal proficiency testing for histocompatibility and immunogenetics in today and future
Oğuz, F. S. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1294330 · Cited by 3
“In recent surveys performed with expert clinicians in Germany and United States, it was reported that 60% – 70% of clinical decisions were in fl uenced by the results of laboratory tests performed both in hospitals and in external centers (Rohr et al., 2016).”
BackgroundAntithrombin: Deficiency, Diversity, and the Future of Diagnostics
Kruijt, M., Cobbaert, C. M., & Ruhaak, L. R. (2025) · Mass Spectrometry Reviews · doi:10.1002/mas.21929 · Cited by 5
Vrijsen, B. E. L., ten Berg, M. J., Naaktgeboren, C. A., Vis, J. Y., Dijstelbloem, H. M., Westerink, J., Dekker, D., Hoefer, I. E., Haitjema, S., Hulsbergen-Veelken, C. A. R., et al. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06453-2 · Cited by 3
Brescia, V., Varraso, L., Antonucci, M., Lovero, R., Schirinzi, A., Mascolo, E., & Serio, F. D. (2023) · Diagnostics · doi:10.3390/diagnostics13061044 · Cited by 3
“All experts agree on non-analytical performance monitoring through the collection and analysis of specific and valuable quality indicators (QI) [22,23].”
BackgroundVloemans, D., Hileghem, L. V., Ordutowski, H., Dosso, F. D., Spasić, D., & Lammertyn, J. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3850-7_1 · Cited by 4
Zayed, A. M., & Delvaux, N. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02536-9 · Cited by 3
“Nevertheless, it influences up to 70% of critical clinical decisions, including decisions regarding admissions, discharges, and medication prescriptions [2].”
BackgroundApproaches to determining the cost of laboratory tests
Хайруллин, И. И., Omelyanovskiy, V. V., Витальевич, Г. Р., Sukhorukikh, O. A., Андреевна, К. С., & GORODETSKY, B. G. (2024) · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · doi:10.17749/2070-4909/farmakoekonomika.2024.245 · Cited by 3
Potockova, H., Dohnal, J., & THOME-KROMER, B. (2020) · Scientific and Technical Review (World Organisation for Animal Health) · doi:10.20506/rst.39.3.3171 · Cited by 4
“Point-of-care testing (POCT), based on the in vitro analysis of biological specimens, is routinely used to detect diseases, monitor therapeutic procedures and provide prognosis (1).”
BackgroundEhrler, F., Tuor, C., Rey, R., Trompier, R., Berger, A., Ramusi, M., Courvoisier, D. S., & Siebert, J. N. (2023) · JMIR Research Protocols · doi:10.2196/43695 · Cited by 4
“Laboratory tests are ordered in nearly 48% of ED visits [8], and 70% of patient-management decisions are based on these tests [9].”
Caballé, I., Soto, A. B., Bernabeu, F. A., Canalías, F., Moreno, A., Ibarz, M., Puzo, J., González, C., & González, Á. (2023) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2023-0013 · Cited by 3
“It is estimated that 66% of clinical decisions are based on laboratory results [4, 5].”
BackgroundMeijer, P., Sobas, F., & Tsiamyrtzis, P. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0835 · Cited by 3
“It has been demonstrated that laboratory testing results play a role in up to 80 % of clinical decision making [1].”
BackgroundYalçındağ, A., Aydın, F. N., Işıklar, Ö. Ö., Can, F., Karademir, M., Uzunal, E., Akyurek, A. O., Yücel, D., & Serdar, M. A. (2024) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2023-0099 · Cited by 3
“Moreover, research on evidence-based clinical guidelines indicates that at least 80 % of guidelines for diagnosis or disease management require laboratory testing [5].”
BackgroundYing, N., Lei, Y., Zhang, T., Lyu, S., Chen, S., Liu, Z., Feng, Y., Zhao, Y., & Zhang, G. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.108148 · Cited by 11
High-Quality Diagnosis: An Essential Pathology Package
Fleming, K. A., Naidoo, M., Wilson, M. L., Flanigan, J. S., Horton, S., Kuti, M. A., Looi, L., Price, C. P., Ru, K., Ghafur, A. K., et al. (2017) · doi:10.1596/978-1-4648-0527-1/pt4.ch11 · Cited by 4
Results of laboratory tests not accessed in Brazilian private laboratories
Shcolnik, W., Galoro, C. A. D. O., Lorencin, M., Donini, R. N., & Jerônimo, D. J. D. S. (2019) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.5935/1676-2444.20190057 · Cited by 6
Bonadies, A., Mancini, R., Maci, M., Gibertoni, C., & Petrini, A. M. (2021) · MECOSAN · doi:10.3280/mesa2020-115005 · Cited by 3
Biopolymeric systems for diagnostic applications
Shreffler, J., Koppelman, M., Mamnoon, B., Mallik, S., & Layek, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821437-4.00022-0 · Cited by 3
Ergonomics knowledge, attitude, and practice among biomedical scientistsPreprint
Alwahaibi, N., Abri, I. A., Sadairi, M. A., & Alrawahi, S. (2021) · medRxiv · doi:10.1101/2021.07.25.21261088 · Cited by 3
“The use of laboratory investigation is very important as 70% of all medical decisions are affected by the results of laboratory analysis (7-9).”
BackgroundCorrection: The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report
Staff, T. P. O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154008 · Cited by 3
Immunoassay System Based on the Technology of Time-Resolved Fluorescence Resonance Energy Transfer
Xu, Z., Zhou, H., Li, L., Chen, Z., Zhang, X., Feng, Y., Wang, J., Li, Y., & Wu, Y. (2024) · Sensors · doi:10.3390/s24051430 · Cited by 2
Halim, A. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816121-0.00011-8 · Cited by 2
Caballé, I., Soto, A. B., Bernabeu, F. A., Canalías, F., Moreno, A., Ibarz, M., Puzo, J., González, C., & González, Á. (2022) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2022-0108 · Cited by 2
“Se estima que en torno al 66% de las decisiones clínicas se basan en los resultados de los laboratorios clínicos [4, 5].”
BackgroundTıbbi Tanı ve Tedavi Cihazlarının Sağlık Harcamaları Üzerindeki Etkisi
Abiş, T., & Çapar, H. (2024) · Süleyman Demirel Üniversitesi Vizyoner Dergisi · doi:10.21076/vizyoner.1261886 · Cited by 2
Kirby, K., Coggins, J., Gibson, A., Liddiard, C., Moore, T. H., Savović, J., Mitchell, K., Thompson, A., Benger, J. R., & Body, R. M. (2024) · NIHR Open Research · doi:10.3310/nihropenres.13580.1 · Cited by 3
Relevance of Personalized Health Care in Patients with Arterial Hypertension: Where are we now?
Binder, C., Schäfer, H. H., Kaiser, E. A., Hund, M., & Dieterle, T. (2016) · InTech eBooks · doi:10.5772/63558 · Cited by 3
“Although cardiologists are known to order general in vitro diagnostic (IVD) tests in 60% of their consultations with the results of these tests influencing diagnosis or treatment decisions in 70% of cases [140], the use of genetic testing is still rare in routine cardiology.”
BackgroundSelf-citationCRISPR based development of RNA editing and the diagnostic platform
Satish, L., Gunamalai, L., Kasthuri, T., Kalaivaani, A., Shamili, S., Muthuramalingam, P., Gowrishankar, S., Pandian, S. K., Singh, V., Sitrit, Y., et al. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.015 · Cited by 2
Autoantibody Assays: Performance, Interpretation, and Standardization
Fritzler, M. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00069-5 · Cited by 3
Il valore della Medicina di Laboratorio
Cappelletti, P., & Golato, M. (2019) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.23736/s1825-859x.19.00039-2 · Cited by 3
COST-EFFECTIVENESS OF LABORATORY TESTING IN AL ZAHRAA TEACHING HOSPITAL, AL NAJAF AL-ASHRAF, IRAQ
Hussein, S. R. M., Abdali, A. M., Khayoon, F. K., Nasrawi, A. J. M., & Sadiq, A. M. (2022) · Wiadomości Lekarskie · doi:10.36740/wlek202207123 · Cited by 1
Guidance On Setting Up A Comprehensive Cancer Centre
INTERNATIONAL ATOMIC ENERGY AGENCY (2024) · International Atomic Energy Agency eBooks · doi:10.61092/iaea.40dy-lc77 · Cited by 3
Wyss, A., Morgenshtern, G., Hirsch-Hüsler, A., & Bernard, J. (2024) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2024.3456329 · Cited by 1
“Conducted outside the human body, diagnostic testing is essential for early disease detection, monitoring, treatment decisions, and consequently: patient care [62].”
BackgroundBenefits, barriers and facilitators for out-of-hospital point of care testing: a qualitative study
Coggins, J., Kirby, K., Body, R. M., & Benger, J. R. (2024) · NIHR Open Research · doi:10.3310/nihropenres.13583.1 · Cited by 1
“EDs currently rely on swift identification of critical conditions through laboratory testing, which guides 60-70% of clinical decisions 15 .”
VitalOne™: a point-of-care platform for rapid, comprehensive, central-lab quality blood testing
Koussa, M. A., Barreiros, M., Perez, P. S. E., Jean, S. R., Lee, T. C., MacLeod, R., Witham, A., Bhat, G., Campbell, T., Lizano, S., et al. (2024) · Sensors & Diagnostics · doi:10.1039/d4sd00105b · Cited by 2
Diagnostic Laboratory Stewardship in a Growing Integrated Delivery Network
Wilhelms, K. W., Braun, D. A., Mochon, A. B., Lainhart, W., Porter, S. M., Beuthin, B. M. A., Blasko, D. M., Shapiro, M. J., & Proytcheva, M. A. (2025) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfae133 · Cited by 1
Beqaj, S., Shrestha, R., & Hamill, T. R. (2025) · Interactive Journal of Medical Research · doi:10.2196/46007 · Cited by 2
Bioanalytical requirements and regulatory guidelines for immunoassays
Vashist, S. K., & Luong, J. H. T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95509-6.00016-1 · Cited by 1
Hill, B. K., Prinzi, A. M., Kane, J. R., Corby, A. K., & Powe, B. D. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf444 · Cited by 1
“%) of the providers highlighted the need for clinical evidence supporting the IVD’s ability to impact patient outcomes [21].”
Urgent samples in clinical laboratories: stochastic batching to minimize patient turnaround time
Novák, A., Gnatowski, A., & Šůcha, P. (2026) · Health Care Management Science · doi:10.1007/s10729-026-09756-8 · Cited by 1
“Many diseases are diagnosed or confirmed by laboratory tests [19].”
LABORATORY MEDICINE AT A CROSSROADS: VALUE, PRIVATIZATION, AND THE FUTURE OF DIAGNOSTIC STEWARDSHIP
Lippi, G. (2026) · Ukrainian Journal of Laboratory Medicine · doi:10.62151/2786-9288.4.1-2.2026.03 · Cited by 1
The severity of harm score database: an evidence-based foundation for laboratory test risk analysis
Çubukçu, H. C., Sonntag, O., Lorde, N., Lefèvre, C. R., Cosma, C., Dalem, A. V., Kanellopoulos, P., Kocijančić, M., Boursier, G., Brguljan, P. M., et al. (2026) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2026-0875 · Cited by 1
“Clinical laboratories play a critical role in patient care, with many clinical decisions in fl uenced by laboratory test results [1].”
Results of Laboratory Tests not Accessed in Brazilian Private Laboratories
Shcolnik, W., Galoro, C. A. D. O., Lorencin, M., Nogueira-Donini, R., & Jerônimo, D. J. D. S. (2018) · Clinical Laboratory · doi:10.7754/clin.lab.2018.180338 · Cited by 1
“Thus, future interventions in the laboratory sector are expected to be directed to the level of resource utilization, the search for efficiency and the elimination of waste((6-8)).”
BackgroundMwape, S., Daka, V., Matafwali, S. K., Mwape, K., Sikalima, J., Vlahakis, P. A., Kalolekesha, M. C., Chisompola, N. K., & Chalwe, V. (2020) · American Journal of Laboratory Medicine · doi:10.11648/j.ajlm.20200505.13 · Cited by 1
Bibikova, V. V., & Emanuel, V. L. (2020) · Laboratory Service · doi:10.17116/labs2020903116 · Cited by 1
Commercialization and safety aspects of biosensing technologies
Marimuthu, M., Kanagaraj, R., Ravichandiran, V., Joseph, J., & Veerapandian, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19039-1.00020-1 · Cited by 1
Bruno, D., du Plessis, C., Rooyen, C. V., Abdallah, S., Abdallah, B., Erdal, E. P., & Apoll, L. (2024) · Journal of Immunological Methods · doi:10.1016/j.jim.2024.113767 · Cited by 1
Fast-track health technology assessment for in vitro diagnostics—a design thinking case study
Victorino, G., Sousa, F. C., Vasconcelos, C., Cordeiro, J. V., Alves, J., & Coelho, P. S. (2024) · BMJ Innovations · doi:10.1136/bmjinnov-2024-001272 · Cited by 1
McKenzie, N. L., Jacobs, J. W., Milner, D. A., & Eichbaum, Q. G. (2025) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaf021 · Cited by 3
Update on Essential Hypertension
Salazar‐Sánchez, L. (2016) · InTech eBooks · doi:10.5772/61565 · Cited by 1
Comparison of precision and operational performances across six immunochemistry analyzers
Findeisen, P., Zahn, I., Rabaneda, C. G., Krempel, D., de Haro-Romero, T., de Haro-Muñoz, T., Barral-Juez, M., Klopprogge, K., & Engelmann, S. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-1275 · Cited by 1
Rani, A., Saxena, A., & Gangopadhyay, S. (2020) · International Journal of Medical Laboratory Research · doi:10.35503/ijmlr.2020.5305 · Cited by 1
Cost, profitability and value of laboratory diagnostics: in God we trust, all others bring data
Lippi, G., & Plebani, M. (2018) · Journal of Laboratory Medicine · doi:10.1515/labmed-2018-0151 · Cited by 1
Variation, errors, and quality in the clinical laboratory
Sepulveda, J. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813776-5.00001-7 · Cited by 1
Candor in medical laboratory management “Quality is doing the right thing and making things right”
Raghavendra Rao, M. V., Bashetti, S., Rekha, A., Kuragayala, S. D., Verma, M. K., Karindas, M. M., Vasiliev, I., Ali, M., & Mallem, D. (2023) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2023.13.3.0139 · Cited by 1
“The significance of laboratory medicine is seen from the fact that 66 % of clinical decisions were based on laboratory tests as shown by a recent study (1).”
BackgroundLippi, G., & Plebani, M. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.09.41 · Cited by 1
“, between 1–2% of the total budget) (1,2), this essential area of science and medicine has been the focus of a large number of too frequently shortsighted political interventions, mainly aimed to reduce the net expenditure rather than targeting inappropriate testing.”
BackgroundLa contribución del laboratorio clínico a la salud poblacional
Martín, I. C. (2016) · Revista del Laboratorio Clínico · doi:10.1016/j.labcli.2016.09.004
Environmental exposure scenario for reagents used in in-vitro diagnostics
Stark-Rogel, V., Urmann, K., Courdouan, A., & Backmann, J. (2020) · Water Research · doi:10.1016/j.watres.2020.115521
Pushkin, A. S., Lyang, O. V., Артыкович, А. Т., & Рукавишникова, С. А. (2020) · Russian Clinical Laboratory Diagnostics · doi:10.18821/0869-2084-2020-65-3-191-196
Makkawi, M. (2021) · Iberoamerican Journal of Medicine · doi:10.53986/ibjm.2021.0037
“Such tests provide a general overview of patient status and assist physicians in the diagnosis and management of disease and its prognosis [10].”
BackgroundSomerville, M., Cassidy, C. E., Curran, J., Rothfus, M. A., Sinclair, D. E., & Rose, A. E. (2022) · Research Square · doi:10.21203/rs.3.rs-1269601/v1
Development of an electrochemical immunosensor for phenylketonuria monitoring
Stewart, A. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.208391
Competitiveness of a clinical laboratory within the Fourth Industrial Revolution
Kadira, B. T., & Rossouw, D. (2023) · Acta Commercii · doi:10.4102/ac.v23i1.1133 · Cited by 2
“za Open Access cornerstone of laboratory medicine and gives precise details on the human body’s current state of health (Rohr et al. 2016).”
BackgroundThe Change of the Vitamin D Test Request Number after the Regulation by the Ministry of Health
Ülgü, M. M., Ata, N., Ertuğrul, D. T., Çağlayan, M., Ayvalı, M. O., Çelik, O., Birinci, Ş., & Kızılgül, M. (2023) · Ankara Medical Journal · doi:10.5505/amj.2023.45712
Contexts of care for people with differences of sex development
Kulle, A. E., Jürgensen, M., Döhnert, U., Malich, L., Marshall, L., & Hiort, O. (2023) · Medizinische Genetik · doi:10.1515/medgen-2023-2037
Stoltz, J., & Govender, K. (2023) · International Review of Management and Marketing · doi:10.32479/irmm.14311
Robust QCM-Based Sensing and Assay Formats in Commercialized Systems
Durall, C., Wallinder, D., Ibrahim, A. E., Nolting, A., Al‐Majdoub, M., Jones, N., Suriyanarayanan, S., Nicholls, I. A., & Aastrup, T. (2023) · Springer series on chemical sensors and biosensors · doi:10.1007/5346_2023_29
Measurement Uncertainty in Specific Hormone Tests
Akşit, M., Terzioğlu, M. E., Akşit, M. Z., Altan, T. K., Başok, B. İ., & Çolak, A. (2023) · Journal of Turkish Clinical Biochemistry · doi:10.56615/tkbd.2023.15
Aldajani, E. S., & Bugis, B. A. (2023) · International Journal of Membrane Science and Technology · doi:10.15379/ijmst.v10i3.3325
“The findings of this study showed that laboratory automation had increased the quality of the test results in the laboratory, which is consistent with the findings of Plebani [6] and Rohr et al. [7].”
BackgroundResultKali, S., Puisney‐Dakhli, C., Delalande, M.-L., Franc, G., Buisson, C., & Barradeau, S. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2024-0389
Are we there yet? AI on traditional blood tests efficiently detects common and rare diseasesPreprint
Németh, Á., Tóth, G., Fülöp, P., Paragh, G., Nádró, B., Karányi, Z., Paragh, G., Horváth, Z., Bagyó, G., Edes, I. F., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4354480/v1
Kirby, K., Coggins, J., Gibson, A., et al. (2024) · NIHR Open Research · doi:10.3310/nihropenres.14741.r31901
Kirby, K., Coggins, J., Gibson, A., et al. (2024) · NIHR Open Research · doi:10.3310/nihropenres.14854.r32406
Ahmad, M., Chin-Yee, B. H., Chin-Yee, I. H., Hedley, B. D., & Hsia, C. C. (2024) · PLOS Digital Health · doi:10.1371/journal.pdig.0000580
Kirby, K., Coggins, J., Gibson, A., et al. (2024) · NIHR Open Research · doi:10.3310/nihropenres.14854.r32407
LeJeune, A., Seymour, D., Graef, K. M., Hategekimana, E., Mbarushimana, D., Ndayisaba, M. C., de Assis, E. A. C. P., Yeabyo, G. O., Nweke, M. C., Berhane, B., et al. (2024) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqae138
Freire, M. D. C., Dias, P. R. T. P., Arcuri, L. J., Souza, T. S., Hirose, C. K., Araújo, P. B., & Neves, M. F. (2024) · Research Square · doi:10.21203/rs.3.rs-5334671/v1
Payment Matters: Understanding Payer Perspectives on Laboratory Stewardship
Astion, M. L., & Baird, G. S. (2025) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfae129
Sun, T., Huang, S., & Ge, M. (2025) · Medicine · doi:10.1097/md.0000000000041883
“[14] Reference intervals serve as a fundamental basis for laboratory assessments, enabling the accurate interpretation of test values in comparison to standard patient populations.”
Shaping the future of medical laboratory practices in Somaliland: a review of the current standards
Alhammadi, O. A. S., Othman, Z. K., Udokang, E. I., Sarfraz, T., Okesanya, O. J., Ogaya, J. B., & Lucero‐Prisno, D. E. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07350-1 · Cited by 1
Metadata
- Authors
- Rohr, U.-P., Binder, C., Dieterle, T., Giusti, F., Messina, C. G. M., Toerien, E., Moch, H., & Schäfer, H. H.
- Affiliations
- University Hospital Zurich (CH)
- Kantonsspital Baselland (CH)
- European Organisation for Research and Treatment of Cancer (NL)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Schäfer, Hans Hendrik
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-03-04
- Volume
- 11
- Issue
- 3
- Pages
- e0149856
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4778800
- OpenAlex
- W2291253625
- Cited by
- 229
- References
- 44
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 43 · 2023: 22 · 2022: 18 · 2021: 23 · 2020: 22 · 2019: 21 · 2018: 20 · 2017: 14 · 2016: 10
- FWCI
- 40.31
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-04-14)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- edoc (University of Basel) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- UpSpace Institutional Repository (University of Pretoria) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Health Professions › General Health Professions › Healthcare cost, quality, practices
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- health care expenditure, physician perceptions, clinical decision-making, diagnostic biomarkers, cost awareness, clinical management
- MeSH terms
- Algorithms, Cardiology, Cost-Benefit Analysis, Data Collection, Diagnostic Tests, Routine, Germany, Humans, Medical Oncology, Practice Patterns, Physicians', Surveys and Questionnaires, United States, Health Care Costs, Decision Support Systems, Clinical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.